C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
12/2002
12/19/2002	CA2450265A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	CA2449629A1 Pyrrolidine derivatives as factor xa inhibitors
12/19/2002	CA2449544A1 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
12/19/2002	CA2449213A1 Ophthalmic compositions comprising hyaluronic acid
12/19/2002	CA2448552A1 Modulators of peroxisome proliferator activated receptors (ppar)
12/19/2002	CA2445653A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
12/18/2002	EP1266897A2 Hypoglycemic imidazoline compounds
12/18/2002	EP1266887A2 Indenoindoline derivatives, their process of preparation and pharmaceutical compositions containing them
12/18/2002	EP1265909A2 Process for the preparation of 6-o-propargyl erythromycin derivatives
12/18/2002	EP1265891A2 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
12/18/2002	EP1265870A1 New ccr5 modulators: benzimidazoles or benzotriazoles
12/18/2002	EP1265863A1 Heterocyclic side chain containing metalloprotease inhibitors
12/18/2002	EP1265862A2 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
12/18/2002	EP1265855A1 Novel cd23 inhibitors
12/18/2002	EP1265853A1 Carboxylic acid derivatives as ip antagonists
12/18/2002	EP1265606A1 Cell adhesion inhibitors
12/18/2002	EP0934300B1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
12/18/2002	EP0930298B1 Fluorinated 1,4-disubstituted piperidine derivatives
12/18/2002	EP0882038B1 substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
12/18/2002	CN1096460C Novel substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for treatment of allergic diseases
12/18/2002	CN1096448C Farnesyl transferase inhibitors, its preparation and medicine composition thereof
12/17/2002	US6495704 Process for the preparation of a derivative or analog of baccatin iii or 10-desacetyl baccatin iii having a c9 substituent other than keto in which the c9 keto substituent of taxol, a taxol analog, baccatin iii or 10-desacetyl
12/17/2002	US6495686 Therapy for psychological disorders
12/17/2002	US6495636 A 3-(ethyleneoxyalkyloxyalkyl)oxetane and derivatives; copolymerized with a 1,1-difluoroethylene or derivative; very compatible and copolymerizable with unsaturated compounds; waterproofing; radiation transparent
12/17/2002	US6495576 N-(1-((3,4-dioxo-2-(3-pyridinylamino)-1-cyclobuten-1-yl)amino) -2,2-dimethylpropyl)-4-methylbenzamide for example; treating bladder overactivity, benign prostatic hyperplasia, premature labor, and sexual disorders
12/17/2002	US6495565 For therapy of acute infection, acute phase response, age related macular degeneration, alcoholism, anorexia, asthma, autoimmune disease, autoimmune hepatitis, bechet's disease, cachexia, calcium pyrophosphate dihydrtate deposition
12/17/2002	US6495552 Treatment or prevention of the diseases and conditions which respond to treatment by retinoids and or which in healthy mammals, including humans, are controlled by natural retinoic acid.
12/17/2002	US6495550 Substituted benzamido-pyridine derivatives for treatment of disorders mediated by potassium channels
12/12/2002	WO2002098873A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/12/2002	WO2002098865A2 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
12/12/2002	WO2002098856A2 Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists
12/12/2002	WO2002098852A2 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins
12/12/2002	WO2002098851A1 Derivatives 0f n,s-substitutions n'-1 [(hetero)aryl] alkyl-n'-[hetero) aryl] methyl isothioureas, method for producing salts and bases thereof, physiologically active n,s-substitutions n'-1 [(hetero)aryl] alkyl-n'-[hetero) aryl] methyl isothioureas, a pharmaceutical composition and curing method
12/12/2002	WO2002076977A3 Rho-kinase inhibitors
12/12/2002	WO2002076976A3 Rho-kinase inhibitors
12/12/2002	WO2002069946A3 Use of triazole compounds for prophylaxis and in therapy for neurodegenerative illnesses, brain traumas and cerebral ischaemia
12/12/2002	WO2002064080A3 Matrix metalloproteinase inhibitors
12/12/2002	WO2002057252A3 Heterocyclic sulfonamide inhibitors of beta amyloid production
12/12/2002	US20020188139 P-thienylbenzylamides as agonists of angiotensin-(1-7) receptors, and methods of their preparartion and use
12/12/2002	US20020188122 Such as pyridine-4-carboxaldehyde-(4-Morpholinylprop-3-yl) imine for use in therapy as cytokine inhibitors
12/12/2002	US20020188120 Such as 4-(4-methyoxy-benzenesulfonyl)-1-(3-phenyl-propyl)-piperidine-4-carboxylic acid hydroxyamide for treatment of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone diseases, diabetes, and HIV
12/12/2002	US20020188017 Thienylazolylalkoxyethanamines, their preparation and their application as medicaments
12/12/2002	US20020188006 4-hydroxypiperidine derivatives having antiarrhythmic activity
12/12/2002	US20020187978 4-Heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
12/12/2002	CA2449771A1 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins
12/12/2002	CA2449109A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/12/2002	CA2446696A1 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
12/11/2002	EP1264827A1 Process for the preparation of Tosylbenzylformamides
12/11/2002	EP1264820A1 Novel amide compounds
12/11/2002	EP1263756A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263755A2 Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263732A1 Corticotropin releasing factor antagonists
12/11/2002	EP1263729A1 Azacyclic compounds for use in the treatment of serotonin related diseases
12/11/2002	EP1263727A1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
12/11/2002	EP1263726A1 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor xa
12/11/2002	EP1263721A1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
12/11/2002	EP1263720A1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
12/11/2002	EP0937064B1 Substituted oximes derivatives useful as neurokinin antagonists
12/11/2002	EP0863891B1 (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors
12/11/2002	EP0662958B1 1-(2-oxo-acetyl)-piperidine-2-carboxylic acid derivatives as multi-drug-resistent cancer cell sensitizers
12/11/2002	CN1384832A Pesticidal aminoheterocyclamide compounds
12/11/2002	CN1384830A Novel spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases
12/11/2002	CN1384100A Benzo-1,3-dioxole and benzofuran substituted pentazane derivative
12/11/2002	CN1095837C Pyridazinone and application as fungicide
12/10/2002	US6492553 A method for preparing a n-((aliphatic or aromatic)carbonyl) )-2-aminoacetamide compound, and for preparing a cyclized compound therefrom, as well as novel resin bound intermediate compounds that are useful for preparing such compounds.
12/10/2002	US6492423 Hepatitis c and b viricides
12/10/2002	US6492416 4,5-diaryl-3(2H)-furanone derivatives as cyclooxygenase-2 inhibitors
12/10/2002	US6492413 For use in therapy of pain, arthritis, fever
12/10/2002	US6492412 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
12/10/2002	US6492411 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
12/10/2002	US6492409 Such as 5-(1-(3-aminopropyl)-3-indolyl)-1-(3-indolyl)-1,3-dihydroimidazol-2-one; protein kinase c inhibitors; high solubility; reduced color; treating inflammatory and/or immunological disorders
12/10/2002	US6492406 Pharmaceutically active compounds
12/10/2002	US6492403 Methods of treating C1s-mediated diseases and conditions and compositions thereof
12/10/2002	US6492402 Anticoagulants; peptide derivatives having high antithrombotic activity and oral bioavailability
12/10/2002	US6492401 Sodium hydrogen exchanger type 1 inhibitors; reducing perioperative myocardial tissue damage
12/10/2002	US6492396 Substituted thioacetamides
12/10/2002	US6492393 Compounds useful as anti-inflammatory agents
12/10/2002	US6492392 2-piperidone compounds
12/10/2002	US6492390 Treating cyclooxygenase-2 mediated disorders.
12/10/2002	US6492388 Such as n-(5-chloro-1,2,3,4-tetrahydroisoquinolin-7-yl)-4-ethoxybenzamide
12/10/2002	US6492372 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
12/10/2002	US6492368 Benzamidine derivatives as factor XA inhibitors
12/10/2002	US6492367 Sulfamato hydroxamic acid metalloprotease inhibitor
12/10/2002	US6492365 Microsomal triglyceride transfer protein
12/10/2002	US6491187 Inverted aerosol dispenser
12/05/2002	WO2002096903A2 Chemical derivatives and the use thereof as an anti-telomerase agent
12/05/2002	WO2002096888A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments
12/05/2002	WO2002096886A1 Pyrimidine derivatives
12/05/2002	WO2002096883A1 Tricyclic compounds useful as angiotensin ii agonists
12/05/2002	WO2002096879A1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
12/05/2002	WO2002096876A1 Carbamate and oxamide compounds as inhibitors of cytokine production
12/05/2002	WO2002096867A2 Inhibitors of protein kinase for the treatment of disease
12/05/2002	WO2002096516A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
12/05/2002	WO2002096426A1 Hydantion derivatives as inhibitors of matrix metalloproteinases
12/05/2002	WO2002081415A3 Method for inhibiting metap2
12/05/2002	WO2001093840A2 Ligands of integrin receptors
12/05/2002	US20020183364 Methods of modulating protein tyrosine kinase function with substituted indolinone compounds
12/05/2002	US20020183361 Heterocyclic sulfonamide inhibitors of beta amyloid production
12/05/2002	US20020183335 2, 4-disubstituted pyrimidine-5-carboxamide derivatives as KCNQ potassium channel modulators
12/05/2002	US20020183334 For therapy of sleepiness, promotion of wakefulness, treatment of Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, treatment of attention deficit hyperactivity disorder

1 ... 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 ... 523